Log In
BCIQ
Print this Print this
 

Coartem, artemether/lumefantrine

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionFixed-dose artemisinin-based combination treatment
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationMalaria
Indication Details 
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today